Description
A typical antipsychotic; dopamine D2 receptor antagonist (Ki = 0.38 nM); 5-HT2A inverse agonist (Ki = 7 nM); reduces cocaine-induced locomotor activity and prevents development of conditioned place preferences for the immediate effects of intravenously administered cocaine in rats at 0.5 mg/kg; inhibits acid sphingomyelinase activity by 81.8% at 10 mM
Formal name: 4-[3-[(3Z)-2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]-1-piperazineethanol, dihydrochloride
Synonyms: cis-Flupentixol
Molecular weight: 507.4
CAS: 51529-01-2
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Product Type|Biochemicals|Receptor Pharmacology|Inverse Agonists||Product Type|Biochemicals|Small Molecule Inhibitors|Sphingolipid Turnover||Research Area|Neuroscience|Behavioral Neuroscience|Addiction Research||Research Area|Neuroscience|Behavioral Neuroscience|Schizophrenia & Psychosis